BIO-RAD LABORATORIES, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
BIO-RAD LABORATORIES, INC. (BIO) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $6.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-08-04
- BIO-RAD LABORATORIES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2026-06-30 was -$1.90M, a 115.83% decline year-over-year.
- BIO-RAD LABORATORIES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2026-03-31 was $8.80M, a 29.41% increase year-over-year.
- BIO-RAD LABORATORIES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2025-12-31 was $5.50M, a 78.00% decline year-over-year.
- BIO-RAD LABORATORIES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2025-09-30 was $4.00M.
- BIO-RAD LABORATORIES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $28.30M, a 32.62% decline from fiscal 2024.
- BIO-RAD LABORATORIES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $42.00M.
- BIO-RAD LABORATORIES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BIO-RAD LABORATORIES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $26.40M, a 1366.67% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $6.90M 10-Q · filed 2026-08-04 | $12.40M derived: sum of 3 quarters · filed 2026-08-04 | $16.40M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $8.80M 10-Q · filed 2026-04-30 | $14.30M derived: sum of 2 quarters · filed 2026-04-30 | $18.30M derived: sum of 3 quarters · filed 2026-04-30 | $30.30M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2025-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $9.50M derived: sum of 2 quarters · filed 2026-02-13 | $21.50M derived: sum of 3 quarters · filed 2026-02-13 | $28.30M 10-K · filed 2026-02-13 | |
| 2025-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $16.00M derived: sum of 2 quarters · filed 2025-10-29 | $22.80M 10-Q · filed 2025-10-29 | $47.80M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2025-06-30 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $18.80M 10-Q · filed 2025-07-31 | $43.80M derived: sum of 3 quarters · filed 2026-02-13 | $38.70M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2025-03-31 | $6.80M 10-Q · filed 2025-05-01 | $31.80M derived: sum of 2 quarters · filed 2026-02-13 | $26.70M derived: sum of 3 quarters · filed 2026-02-13 | $47.50M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $19.90M derived: sum of 2 quarters · filed 2026-02-13 | $40.70M derived: sum of 3 quarters · filed 2026-02-13 | $42.00M 10-K · filed 2026-02-13 | |
| 2024-09-30 | -$5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $15.70M derived: sum of 2 quarters · filed 2024-10-31 | $17.00M 10-Q · filed 2024-10-31 | $1.80M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-06-30 | $20.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $22.10M 10-Q · filed 2024-08-02 | $6.90M derived: sum of 3 quarters · filed 2026-02-13 | $2.10M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-03-31 | $1.30M 10-Q · filed 2024-05-08 | -$13.90M derived: sum of 2 quarters · filed 2026-02-13 | -$18.70M derived: sum of 3 quarters · filed 2026-02-13 | ||
| 2023-12-31 | -$15.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$20.00M derived: sum of 2 quarters · filed 2026-02-13 | $0.00 10-K · filed 2026-02-13 | ||
| 2023-09-30 | -$4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $15.20M 10-Q · filed 2023-10-27 | |||
| 2023-06-30 | $20.00M 10-Q · filed 2023-08-04 | ||||
| 2022-12-31 | $26.40M 10-K · filed 2025-02-14 | ||||
| 2021-12-31 | $1.80M 10-K · filed 2024-02-16 | ||||
| 2020-12-31 | $0.00 10-K · filed 2023-02-17 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-02-11 | $3.60M 10-K · filed 2020-03-02 | |||
| 2018-12-31 | $4.40M 10-K · filed 2021-02-16 |